Live Quote · NASDAQXERSHealthcare· Biotechnology

Xeris Biopharma Holdings, Inc.

$16.97▲ 2.11%(+$0.35)
MKT CAP $3.10BNEXT EARNINGS Mar 1, 2027
50%
Bullish
TickerSpark Score
67/100
▌ Solid
44
Valuation
40
Profitability
100
Growth
52
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XERS research report →

Analyst Price Target
$15.00-11.6% vs. today

Range $14 – $16

Analyst RatingBuy
10 Buy1 Hold0 Sell

Price Chart

+144.74% · this period
$16.99$11.14$5.29Nov 20May 26Nov 20
52-Week Range97% of range
Low
$5.25
Current
$16.97
High
$17.28